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Itend to tell students, when appropriate, thatstatistics are like menstruation – not leastbecause it momentarily wrests them from day-
dreams or from texting each other. The latter, before
we humans invented society with its higher ideals,
was an admission of failure to conceive.  Statistical
analysis in science is an admission of failure to get
to grips with experiments and have all the variables
under control.  Noticeably, the ‘harder’ the science
the less are statistics necessary.  In journals of
chemistry or physics they feature relatively little;
move nearer to the diversity of life (no coincidence
SPSS is so named) and reliance on statistics to restore order amid
chaos is vast.  Between these extremes and at their best they
impose a discipline of restraint on how results are viewed.
It is unsurprising that in this quite optimistic issue of Oncology
News, the entirely descriptive article – on trends in radiotherapy
– is most up-beat (alongside the conference report on melanoma
treatment) and almost declares the end of the road in cancer
therapy in sight! Descriptive work is fine.  Among the seminal
papers of the last 60 years, from DNA structure (just one and a
half columns in Nature 1953) through monoclonal antibodies,
PCR and DNA microarrays, original descriptions lack a statistical
requirement. There are qualitative themes running through the
more quantitative articles in this issue too. It is nice to see
targeted therapies, be they tyrosine-kinase inhibitors or
monoclonal antibodies, getting somewhere against common solid
tumours. Indeed, the radiotherapy story also describes successful
targeting, albeit spatial, rather than physiological 
Order created statistically is to an extent illusory. It is hugely
useful to put a figure on the amount of uncertainty we have
about results, but to be pretty certain about something
unimportant or trumped by other considerations, is not helpful.
It is also a pity that in thus computer age we are left with baggage
from the era of printed look-up tables for statistical relevance.The
0.05 p-value, reputedly conceived in a pub early in the 20th
century has limited value today when a precise figure can be
obtained easily and viewed for what it is worth.  Given a 75%
chance of finding a £50 note down the back of a sofa, I’d go a
few extra yards for a quick look!  
So the article on non-small cell lung cancer and conference
report on metastatic colorectal cancer both report progress
numerically and with statistical back-up but behind the figures
the progress is incremental rather than seismic. Even the striking
results on metastatic melanoma, described in seismic terms,
means for a patient only a 50-50 chance of surviving two years.
Obtaining quantitative results that stand statistical
scrutiny means selection – of patients, lesions and
measurements as formally defined in Response
Evaluation Criteria in Solid Tumours. This
reductionism can build a parallel universe where
clinicians know well how best to treat patients who
would be eligible for an RCT, but arguably short-
changes the many who would have been excluded.
Two articles in this issue deal with the real raw
world. One concerns screening, which is
intrinsically inclusive.  Statistics are important in
determining efficiency there. The other describes a
computerised work management system, the value of which is
not apparently so much its actual output, as being the motivator
that gets different practitioners interacting.
Another illusion prevalent about statistics is that,
computational power apart, they are like Latin: a hugely
important but more or less dead language.  Journals of statistics
for statisticians (not necessarily medical) are full of controversy.
It’s not necessary to understand fully the arguments to realise
that hypothesis testing is not the only route for statistical analysis
and that familiar procedures are the subject of ongoing research
and debate. Asked long ago to recommend a course in
experimental methodology I was then running, a professor of
surgery replied that his lads were taught statistics, so they were
covered. There is more to designing a good experiment than
getting your power calculation right. The stats lobby is strong and
mysterious. Journals feel obliged to employ in-house statistical
advisors but leave other aspects of experimental design to ‘peer
review’: a blunt instrument indeed and a topic for another
occasion.
Tennyson was not quite right about his brook. Its course,
features and usage are subject to natural and man-made change.
So the features and usage of statistics in medicine will change.
Our view of them should certainly become less reverential, but
they will still be there when microarrays and metabolic pathway
inhibitors are old hat. Unless we can get a grip on all those
variables! But mathematical modelling in biomedicine on that
scale is at best embryonic and with a long gestation ahead. 
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